Integra Lifesciences Holdings Corp (NAS:IART)
$ 19.73 +0.94 (+5.03%) Market Cap: 1.53 Bil Enterprise Value: 3.31 Bil PE Ratio: 0 PB Ratio: 1.47 GF Score: 71/100

Q2 2025 Integra Lifesciences Holdings Corp Earnings Call Transcript

Jul 31, 2025 / 12:30PM GMT
Release Date Price: $13.14 (+6.22%)
Operator

Good day and thank you for standing by. Welcome to the Integra Lifesciences second quarter 2025 financial results call. (Operator Instructions)

Please be advised that today's conference is being recorded. I'd like to hand a conference over to your first speaker today, Chris Ward, Senior Director of Investor Relations. Please go ahead.

Chris Ward
Integra Lifesciences Holdings Corp - IR Contact Officer

Good morning and thank you for joining the Integral Lifesciences second quarter 2025 earnings conference call. With me on the call are Mojdeh Poul, President and Chief Executive Officer, and Lea Knight, Chief Financial Officer.

Earlier this morning, we issued a press release announcing our second quarter of 2025 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integralife.com under Investors events and Presentation and a file named second quarter 2025 earnings calls presentation.

Before we begin, I want to remind you that many of the statements made during

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot